Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [2]
        • LPEP Programme
        • PEP++ project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Autoantibodies and vitamin D in leprosy patients in the Brazilian Amazon.

da Silva G, Aarão T, Modesto L, et al. BMC infectious diseases. 2026;
Download PDF
Publication

Relationship between social participation and stigma in people affected by leprosy: A cross-sectional study in northeastern Brazil.

Lima M, de Arruda G, Alves M, et al. Belitung nursing journal. 2026; 12 (1) : 49-57.
Download PDF
Publication

Impact of Dapsone (MDT/WHO) on hematological tests of leprosy patients: A retrospective cohort study

da Silva CM, Albertino GS, Wiezel JA, et al. openRxiv. 2025;
Download PDF
Publication

Type 1 leprosy reaction in a patient coinfected with HTLV-1 and Mycobacterium leprae

Faria LGAP, Moura MN, da Cruz ALB, et al. Elsevier BV. Clinical Microbiology Newsletter. 2026;
Download PDF
Publication

Reactivations, paradoxical reactions, and immune reconstitution in human immunodeficiency virus-associated leprosy: A scoping review of global case patterns, immunopathogenesis, and therapeutic gaps

Anil A, Vellaisamy SG, Manickam N, et al. Ovid Technologies (Wolters Kluwer Health). Indian Journal of Sexually Transmitted Diseases and AIDS. 2025; 46 (2) : 112-118.
Download PDF
Publication

CCDC122-LACC1 gene polymorphism is associated with protection against leprosy in a population from Northeastern Brazil: a case-control study

Freitas HDA, Nogueira KRC, Costa ARRS, et al. Springer Science and Business Media LLC. BMC Infectious Diseases. 2025; 25 (1) : 1-11.
Download PDF
Publication

Determinants of Delayed Leprosy Diagnosis in an Endemic Area of Northeast Brazil: A Cross-Sectional Study

Pina WLDSM, Melo LFDA, Rocha HND, et al. FapUNIFESP (SciELO). Revista da Sociedade Brasileira de Medicina Tropical. 2025;
Download PDF
Publication

Leprosy elimination: are we winning the fight or losing focus?

Edward M, Owoicho AW. Informa UK Limited. Annals of Medicine. 2025; 57 (1) : 1-9.
Download PDF
Publication

Self-assessment of risk of dysphagia and clinical-functional vulnerability in older adults with a history of leprosy

Rocha MC, Mourão AM, Jesus JDSD, et al. FapUNIFESP (SciELO). CoDAS. 2025; 37 (6) : 1-8.
Download PDF
Publication

Factors associated with non-adherence to polychemotherapy treatment for leprosy.

da Cruz J, Franchi E. Revista brasileira de enfermagem. 2025; 78 (4) : 1-10.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 3
  • Next page ››
Subscribe to Brazil

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD